FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
9 letters match. Newest first.
-
BiologicsCentral Coast Multispecialty Medical Group, Inc.
FDA warns Central Coast Multispecialty Medical Group over incomplete donor screening and eligibility for reproductive tissue.
High risk -
BiologicsConceive Fertility Center
FDA says Conceive Fertility Center in Dallas used incomplete donor screening and testing for reproductive cells.
High risk -
BiologicsLouisville Reproductive Center
Louisville Reproductive Center failed to properly test and screen semen donors for infectious diseases, FDA found.
High risk -
BiologicsGreen Valley Fertility Partners
FDA cited Green Valley Fertility Partners for donor eligibility failures involving oocyte HCT/Ps, including missing communicable disease testing and screening.
High risk -
BiologicsSperm Bank, Inc. dba Fertility Center of California
FDA warned Sperm Bank, Inc. dba Fertility Center of California over donor semen released without required infectious-disease testing and screening.
High risk -
BiologicsAkan Biosciences, Inc.
FDA warned Akan Biosciences over unapproved Ayama injectable and donor-screening failures.
High risk -
BiologicsMark S. Denker, M.D., PA dba Palm Beach Fertility Center
FDA warns Boca Raton fertility center over failures to screen sperm and egg donors for infectious disease risk.
High risk -
BiologicsCryos International USA LLC
Cryos International USA released and distributed anonymous donor semen without required infectious disease testing and quarantine.
High risk -
BiologicsCooper Institute
FDA warned Houston fertility clinic Cooper Institute that it failed to test and screen oocyte donors for infectious diseases.
High risk